Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
-2.4%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$46.6B
AUM Growth
+$252M
(+0.54%)
Cap. Flow
+$1.72B
Cap. Flow
% of AUM
3.69%
Top 10 Holdings %
Top 10 Hldgs %
24.5%
Holding
2,693
New
484
Increased
604
Reduced
645
Closed
636
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.85B |
| 2 |
Humana
HUM
|
+$493M |
| 3 |
Kenvue
KVUE
|
+$466M |
| 4 |
AbbVie
ABBV
|
+$448M |
| 5 |
Microsoft
MSFT
|
+$367M |
Top Sells
| 1 |
Amazon
AMZN
|
+$709M |
| 2 |
Apple
AAPL
|
+$528M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$479M |
| 4 |
McKesson
MCK
|
+$358M |
| 5 |
Intel
INTC
|
+$306M |
Sector Composition
| 1 | Technology | 20.98% |
| 2 | Healthcare | 18.01% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Consumer Staples | 7.98% |
| 5 | Financials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Ziff Davis
ZD
$1.5B
| $581K | ﹤0.01% |
+9,117
| New | +$581K |
|
1377
Rocket Companies
RKT
$44.4B
| $576K | ﹤0.01% |
70,395
+42,795
| +155% | +$350K |
|
1378
Oportun Financial
OPRT
$293M
| $575K | ﹤0.01% |
79,632
+64,832
| +438% | +$468K |
|
1379
Savers
SVV
$1.94B
| $571K | ﹤0.01% |
30,579
-70,066
| -70% | -$1.31M |
|
|
INZY
1380
DELISTED
Inozyme Pharma
INZY
| $570K | ﹤0.01% |
135,783
+7,876
| +6% | +$33.1K |
|
1381
Inter&Co
INTR
$3.92B
| $570K | ﹤0.01% |
142,480
-56,756
| -28% | -$227K |
|
|
EXE
1382
Expand Energy Corporation Common Stock
EXE
$22.9B
| $570K | ﹤0.01% |
6,607
-108,393
| -94% | -$9.35M |
|
1383
Universal Electronics
UEIC
$62.3M
| $568K | ﹤0.01% |
62,748
+40,330
| +180% | +$365K |
|
1384
Puma Biotechnology
PBYI
$225M
| $563K | ﹤0.01% |
214,213
-10,580
| -5% | -$27.8K |
|
1385
Duke Energy
DUK
$94.8B
| $561K | ﹤0.01% |
6,355
-252,504
| -98% | -$22.3M |
|
1386
iShares Russell 1000 Growth ETF
IWF
$120B
| $559K | ﹤0.01% |
2,100
+1,263
| +151% | +$336K |
|
1387
Ameresco
AMRC
$1.44B
| $557K | ﹤0.01% |
14,451
-116,594
| -89% | -$4.5M |
|
1388
Stellus Capital Investment Corp
SCM
$402M
| $557K | ﹤0.01% |
40,950
-71,525
| -64% | -$973K |
|
1389
MediaAlpha
MAX
$688M
| $556K | ﹤0.01% |
67,364
-55,640
| -45% | -$460K |
|
|
ESTE
1390
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $556K | ﹤0.01% |
27,456
-823,025
| -97% | -$16.7M |
|
1391
Kimbell Royalty Partners
KRP
$1.26B
| $555K | ﹤0.01% |
+34,702
| New | +$555K |
|
1392
iShares US Telecommunications ETF
IYZ
$607M
| $555K | ﹤0.01% |
+26,060
| New | +$555K |
|
1393
Lands' End
LE
$475M
| $554K | ﹤0.01% |
74,230
-86,828
| -54% | -$649K |
|
1394
Mesa Laboratories
MLAB
$339M
| $554K | ﹤0.01% |
+5,276
| New | +$554K |
|
1395
Automatic Data Processing
ADP
$119B
| $553K | ﹤0.01% |
2,300
+377
| +20% | +$90.7K |
|
1396
United Therapeutics
UTHR
$18.3B
| $553K | ﹤0.01% |
+2,448
| New | +$553K |
|
1397
Regenxbio
RGNX
$465M
| $547K | ﹤0.01% |
+33,249
| New | +$547K |
|
1398
Iris Energy
IREN
$9.24B
| $545K | ﹤0.01% |
146,777
-22,061
| -13% | -$81.8K |
|
1399
Emergent Biosolutions
EBS
$434M
| $543K | ﹤0.01% |
159,780
-25,784
| -14% | -$87.7K |
|
1400
Y-mAbs Therapeutics
YMAB
$390M
| $539K | ﹤0.01% |
98,931
-28,737
| -23% | -$157K |
|